Log In
BCIQ
Print this Print this
 

Subcutaneous GSK3196165 (formerly Subcutaneous MOR103)

  Manage Alerts
Collapse Summary General Information
Company MorphoSys AG
DescriptionSubcutaneous formulation of a HuCal antibody against GM-CSF
Molecular Target Granulocyte macrophage colony-stimulating factor (GM-CSF) receptor (CSF2RA) (GMR) (CD116)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today